Cargando…

Characterization of Behavioral, Signaling and Cytokine Alterations in a Rat Neurodevelopmental Model for Schizophrenia, and Their Reversal by the 5-HT(6) Receptor Antagonist SB-399885

Post-weaning social isolation of rats produces neuroanatomical, neurochemical and behavioral alterations resembling some core features of schizophrenia. This study examined the ability of the 5-HT(6) receptor antagonist SB-399885 to reverse isolation-induced cognitive deficits, then investigated alt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shortall, Sinead E., Negm, Ola H., Fowler, Maxine, Fairclough, Lucy C., Tighe, Patrick J., Wigmore, Peter M., King, Madeleine V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096968/ https://www.ncbi.nlm.nih.gov/pubmed/29423817 http://dx.doi.org/10.1007/s12035-018-0940-0

Ejemplares similares

Calbindin Deficits May Underlie Dissociable Effects of 5-HT(6) and mGlu(7) Antagonists on Glutamate and Cognition in a Dual-Hit Neurodevelopmental Model for Schizophrenia
por: Shortall, Sinead E., et al.
Publicado: (2020)

Effects of the Selective 5-HT7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-like Deficits in Rats
por: Nikiforuk, Agnieszka, et al.
Publicado: (2013)

Development and Validation of Protein Microarray Technology for Simultaneous Inflammatory Mediator Detection in Human Sera
por: Selvarajah, Senthooran, et al.
Publicado: (2014)

The 5-HT(2C) receptor agonist, lorcaserin, and the 5-HT(6) receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour
por: Higgs, Suzanne, et al.
Publicado: (2015)

A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS)
por: Negm, Ola H, et al.
Publicado: (2014)

The 5-HT(7) receptor antagonist SB 269970 ameliorates corticosterone-induced alterations in 5-HT(7) receptor-mediated modulation of GABAergic transmission in the rat dorsal raphe nucleus
por: Sowa, Joanna, et al.
Publicado: (2018)

Multiple Circulating Cytokines Are Coelevated in Chronic Obstructive Pulmonary Disease
por: Selvarajah, Senthooran, et al.
Publicado: (2016)

Acute 5-HT(2C) Receptor Antagonist SB-242084 Treatment Affects EEG Gamma Band Activity Similarly to Chronic Escitalopram
por: Papp, Noémi, et al.
Publicado: (2020)

Neurodevelopmental hypothesis of schizophrenia
por: Owen, Michael J., et al.
Publicado: (2011)

OR13-005 – Investigation of clinical and laboratory significance of TNFRSF1A intron by reverse-phase protein microarray
por: Drewe, E, et al.
Publicado: (2013)

Altered cytokine pattern and inflammatory pathways in monogenic and complex autoinflammatory diseases
por: Galozzi, P, et al.
Publicado: (2015)

The serotonin 5-HT3 receptor: a novel neurodevelopmental target
por: Engel, Mareen, et al.
Publicado: (2013)

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT(3) receptors
por: Lochner, Martin, et al.
Publicado: (2016)

Azologization of serotonin 5-HT(3) receptor antagonists
por: Rustler, Karin, et al.
Publicado: (2019)

Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor
por: Lee, Jieon, et al.
Publicado: (2021)

The intracellular signalling pathway signature (the signalome) in PBMCs in the presence of a common TRAPS-associated genetic variant, TNFRSF1A p.(Arg121Gln) (legacy p.R92Q) is distinct from normal PBMCs and from other pathogenic variants
por: Bybee, A, et al.
Publicado: (2015)

Cytokines and the neurodevelopmental basis of mental illness
por: Ratnayake, Udani, et al.
Publicado: (2013)

Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats
por: Fijał, Katarzyna, et al.
Publicado: (2013)

SB-273005, an antagonist of αvβ3 integrin, reduces the production of Th2 cells and cytokine IL-10 in pregnant mice
por: WANG, SHAOJUAN, et al.
Publicado: (2014)

Computational approaches for the design of novel dopamine D(2) and serotonin 5-HT(2A) receptor dual antagonist towards schizophrenia
por: Rathore, Akash, et al.
Publicado: (2022)

Neurodevelopmental and environmental hypotheses of negative symptoms of schizophrenia
por: Limosin, Frédéric
Publicado: (2014)

5-HT3 and 5-HT4 antagonists inhibit peristaltic contractions in guinea-pig distal colon by mechanisms independent of endogenous 5-HT
por: Sia, Tiong C., et al.
Publicado: (2013)

Constitutively Active 5-HT Receptors: An Explanation of How 5-HT Antagonists Inhibit Gut Motility in Species Where 5-HT is Not an Enteric Neurotransmitter?
por: Spencer, Nick J.
Publicado: (2015)

Sb(2)S(3) Thickness-Related Photocurrent and Optoelectronic Processes in TiO(2)/Sb(2)S(3)/P3HT Planar Hybrid Solar Cells
por: Wu, Fan, et al.
Publicado: (2019)

A Pro-Inflammatory Signature Constitutively Activated in Monogenic Autoinflammatory Diseases
por: Galozzi, Paola, et al.
Publicado: (2022)

On the decay of 110Sb, 111Sb, 112Sb, 113Sb and 114Sb
por: Sunier, J W, et al.
Publicado: (1970)

IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review
por: Saniklidou, Ariadne Hadjikyriacou, et al.
Publicado: (2017)

ELISA in the multiplex era: Potentials and pitfalls
por: Tighe, Patrick J., et al.
Publicado: (2015)

Electronic cigarette vapour moderately stimulates pro-inflammatory signalling pathways and interleukin-6 production by human monocyte-derived dendritic cells
por: Chen, I-Ling, et al.
Publicado: (2020)

Functional group interactions of a 5-HT(3)R antagonist
por: Venkataraman, Padmavati, et al.
Publicado: (2002)

Role of 5-HT(2A) receptor antagonists in the treatment of insomnia
por: Vanover, Kimberly E, et al.
Publicado: (2010)

5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
por: Andrews, Megan, et al.
Publicado: (2018)

Effects of 5‐HT(₃) receptor antagonists on cisplatin‐induced kidney injury
por: Goda, Mitsuhiro, et al.
Publicado: (2021)

SB 206553, a putative 5-HT(2C) inverse agonist, attenuates methamphetamine-seeking in rats
por: Graves, Steven M, et al.
Publicado: (2012)

Superiority of the Triple-Acting 5-HT(6)R/5-HT(3)R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT(6)R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats
por: Grychowska, Katarzyna, et al.
Publicado: (2023)

Considering the Microbiome in Stress-Related and Neurodevelopmental Trajectories to Schizophrenia
por: Hoffman, Kevin W., et al.
Publicado: (2020)

Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013)

Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT(1A) and 5-HT(7) Antagonists in Animal Models
por: Pytka, Karolina, et al.
Publicado: (2015)

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists.
por: de Boer-Dennert, M., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_br9qccn443jo1qafs1eibk4ph4